Rivia unveils AI-driven DataFindings module to accelerate clinical trial data cleaning, Scancell adopts early
Swiss CRO Rivia introduced an AI-powered DataFindings module that integrates with its Rivia Core platform to automate continuous review of clinical trial data.
The tool uses AI agents to help users create data review rules, then monitors trial data for changes, flagging issues for attention and allowing task assignment with a full audit trail.
Rivia says the automation can reduce delays caused by unresolved data issues that slow the transition from trial completion to analysis and regulatory submission.
U.K.-based biotech Scancell serves as the design partner and first adopter of the new module.
This writeup was produced by pharmadog from original reporting by Fierce Biotech.
Original headline: “Rivia launches AI-powered clinical trial data review module, with Scancell as early adopter”
read at Fierce Biotech ↗
comments(0)
5-min edit window · permanent after that